43 related articles for article (PubMed ID: 24852425)
1. MicroRNA-638 expression change in osteosarcoma patients via PLD1 and VEGF expression.
Xue M; Shen J; Cui J; Wu J; Qiao W; Ding N; Song C; Shan B
Exp Ther Med; 2019 May; 17(5):3899-3906. PubMed ID: 30988774
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of Twist, vascular endothelial growth factor and CD34 in patients with different phases of osteosarcoma.
Lei P; Ding D; Xie J; Wang L; Liao Q; Hu Y
Oncol Lett; 2015 Jul; 10(1):417-421. PubMed ID: 26171042
[TBL] [Abstract][Full Text] [Related]
3. A systematic review of vascular endothelial growth factor expression as a biomarker of prognosis in patients with osteosarcoma.
Chen D; Zhang YJ; Zhu KW; Wang WC
Tumour Biol; 2013 Jun; 34(3):1895-9. PubMed ID: 23589053
[TBL] [Abstract][Full Text] [Related]
4. Comment on Xu XW et al.: Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
He S; Xiao Z; Chen L; Xiong S
Tumour Biol; 2014 Jul; 35(7):6193-4. PubMed ID: 24852425
[No Abstract] [Full Text] [Related]
5. The prognostic value of elevated vascular endothelial growth factor in patients with osteosarcoma: a meta-analysis and systemic review.
Qu JT; Wang M; He HL; Tang Y; Ye XJ
J Cancer Res Clin Oncol; 2012 May; 138(5):819-25. PubMed ID: 22274866
[TBL] [Abstract][Full Text] [Related]
6. Letter regarding "Prognostic role of cytovillin expression in patients with osteosarcoma: a meta-analysis" by Guo et al.
Wang P; Sun L; Yu L; Wang H
Tumour Biol; 2014 Jul; 35(7):6175. PubMed ID: 24504679
[No Abstract] [Full Text] [Related]
7. Transferrin receptor-1 and VEGF are prognostic factors for osteosarcoma.
Wu H; Zhang J; Dai R; Xu J; Feng H
J Orthop Surg Res; 2019 Sep; 14(1):296. PubMed ID: 31484533
[TBL] [Abstract][Full Text] [Related]
8. Comment on Zhuang YF et al.: impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Ma J; Fang L; Zhang F
Tumour Biol; 2014 Sep; 35(9):8533-4. PubMed ID: 25113255
[No Abstract] [Full Text] [Related]
9. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
[TBL] [Abstract][Full Text] [Related]
10. [Expression of hypoxia-inducible factor 1α in osteosarcoma and its value in predicting chemosensitivity].
Chen Y; Wang CM; Shi YQ; Yang Y
Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):899-904. PubMed ID: 23336375
[TBL] [Abstract][Full Text] [Related]
11. A prognostic evaluation of vascular endothelial growth factor in children and young adults with osteosarcoma.
Ługowska I; Woźniak W; Klepacka T; Michalak E; Szamotulska K
Pediatr Blood Cancer; 2011 Jul; 57(1):63-8. PubMed ID: 21416580
[TBL] [Abstract][Full Text] [Related]
12. Expression of molecular markers in the tumor and survival prognosis in osteosarcoma.
Boulytcheva IV; Soloviev YN; Kushlinskii NE; Mahson AN
Bull Exp Biol Med; 2010 Dec; 150(2):237-42. PubMed ID: 21240382
[TBL] [Abstract][Full Text] [Related]
13. VEGF and EMMPRIN expression correlates with survival of patients with osteosarcoma.
Zhou Q; Zhu Y; Deng Z; Long H; Zhang S; Chen X
Surg Oncol; 2011 Mar; 20(1):13-9. PubMed ID: 19836228
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
